Risk of Throat Cancer from Fosamax, Actonel, Boniva Found in Study
Long-term users of the bone-strengthening drugs Fosamax, Actonel, Boniva and other oral bisphosphonates may face a doubled risk of throat cancer, according to the results of a new study.
The study is published in the latest issue of the British Medical Journal (BMJ), and it appears to contradict a similar study published last month that found no link between oesophageal cancer and oral biphosphonates like Fosamax.
Researchers from Oxford University looked at the UK General Practice Research Database and found that those subjects who filled 10 or more prescriptions for oral biphosphonates had nearly twice the chance of contracting throat cancer than those who were not taking the drugs. Researchers said that risk did not change regardless of age, sex, smoking, alcohol use, weight or the use of a variety of other drugs.
See the original article here: https://www.aboutlawsuits.com/risk-throat-cancer-from-fosamax-found-12595/
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.
|Personal Injury Lawsuits||Mass Torts|
Click here to see the original article.